Bioadhesive Drug Delivery System for Enhancing the Permeability of a BCS Class III Drug Via Hot-Melt Extrusion Technology

Overview

Journal AAPS PharmSciTech

Publisher Springer

Specialty Pharmacology

Date 2017 Mar 2

PMID 28247291

Citations 7

Authors

Nicole S Mendonsa

Priyanka Thipsay

Dong Wuk Kim

Scott T Martin

Michael A Repka

Affiliations

Soon will be listed here.

Abstract

As the buccal route of administration has the ability to avoid the GI tract and first-pass effect by directing the absorption toward the cheek area, the bioavailability of BCS class III drugs can be increased through this route. Only a handful of studies have been conducted using oleic acid as a permeation enhancer in any transbuccal drug delivery system. Therefore, the objectives of this novel study were to develop a buccal tablet using two concentrations of oleic acid for a model BCS class III drug via hot-melt extrusion technology and to investigate the effects of oleic acid on the physicochemical properties of the tablet. The model drug selected was ondansetron hydrochloride. Formulations consisting of polymers (hydroxypropyl methylcellulose and polyethylene oxide) and two concentrations of oleic acid were prepared by hot-melt extrusion techniques. A melting point depression of the drug was obtained in the extruded granules as seen by the DSC thermograms. The ex vivo permeation studies showed a greater permeation of the drug in the formulation containing 10% oleic acid (F2) as compared to the formulation containing 20% oleic acid (F1), although not statistically significant. The in vitro bioadhesion studies, swelling studies, and surface pH measurements of the tablets were also conducted. In conclusion, permeation studies exhibited the potential of oleic acid as a buccal permeation enhancer as a significant permeation of the drug was obtained in the formulations. Hot-melt extrusion technology was successfully employed to formulate buccal tablets of ondansetron hydrochloride.

Citing Articles

Investigation of Cellular Interactions of Lipid-Structured Nanoparticles With Oral Mucosal Epithelial Cells.

Jeitler R, Glader C, Tetyczka C, Zeiringer S, Absenger-Novak M, Selmani A Front Mol Biosci. 2022; 9:917921.

PMID: 35677878 PMC: 9170126. DOI: 10.3389/fmolb.2022.917921.

Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance.

Bandari S, Nyavanandi D, Dumpa N, Repka M Adv Drug Deliv Rev. 2021; 172:52-63.

PMID: 33571550 PMC: 8107127. DOI: 10.1016/j.addr.2021.02.006.

Synthesis and Characterization of Lipophilic Salts of Metformin to Improve Its Repurposing for Cancer Therapy.

Saeed H, Sutar Y, Patel P, Bhat R, Mallick S, Hatada A ACS Omega. 2021; 6(4):2626-2637.

PMID: 33553880 PMC: 7859945. DOI: 10.1021/acsomega.0c04779.

Manufacturing strategies to develop amorphous solid dispersions: An overview.

Mendonsa N, Almutairy B, Raman Kallakunta V, Sarabu S, Thipsay P, Bandari S J Drug Deliv Sci Technol. 2020; 55.

PMID: 32863891 PMC: 7453425. DOI: 10.1016/j.jddst.2019.101459.

A quality by design approach to develop topical creams via hot-melt extrusion technology.

Mendonsa N, Pradhan A, Sharma P, Prado R, Murthy S, Kundu S Eur J Pharm Sci. 2019; 136:104948.

PMID: 31173868 PMC: 6918693. DOI: 10.1016/j.ejps.2019.06.002.

References

Larrucea E, Arellano A, Santoyo S, Ygartua P . Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin. Eur J Pharm Biopharm. 2001; 52(2):113-9. DOI: 10.1016/s0939-6411(01)00158-8. View

Tiwari R, Patil H, Repka M . Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century. Expert Opin Drug Deliv. 2016; 13(3):451-64. DOI: 10.1517/17425247.2016.1126246. View

Langer R, Peppas N . Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials. 1981; 2(4):201-14. DOI: 10.1016/0142-9612(81)90059-4. View

Nicolazzo J, Reed B, Finnin B . Buccal penetration enhancers--how do they really work?. J Control Release. 2005; 105(1-2):1-15. DOI: 10.1016/j.jconrel.2005.01.024. View

Lee J, Kellaway I . Combined effect of oleic acid and polyethylene glycol 200 on buccal permeation of [D-ala2, D-leu5]enkephalin from a cubic phase of glyceryl monooleate. Int J Pharm. 2000; 204(1-2):137-44. DOI: 10.1016/s0378-5173(00)00490-7. View

Shojaei A . Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci. 2000; 1(1):15-30. View

Cho E, Gwak H, Chun I . Formulation and evaluation of ondansetron nasal delivery systems. Int J Pharm. 2007; 349(1-2):101-7. DOI: 10.1016/j.ijpharm.2007.07.028. View

Korsmeyer R, Gurny R, Doelker E, Buri P, Peppas N . Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air. J Pharm Sci. 1983; 72(10):1189-91. DOI: 10.1002/jps.2600721021. View

Khullar P, Khar R, Agarwal S . Evaluation of guar gum in the preparation of sustained-release matrix tablets. Drug Dev Ind Pharm. 1999; 24(11):1095-9. DOI: 10.3109/03639049809089955. View

10.

Hassan N, Khar R, Ali M, Ali J . Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondansetron. AAPS PharmSciTech. 2009; 10(4):1085-92. PMC: 2799570. DOI: 10.1208/s12249-009-9304-4. View

11.

Jones E, Ojewole E, Pillay V, Kumar P, Rambharose S, Govender T . Monolayered multipolymeric buccal films with drug and polymers of opposing solubilities for ARV therapy: physico-mechanical evaluation and molecular mechanics modelling. Int J Pharm. 2013; 455(1-2):197-212. DOI: 10.1016/j.ijpharm.2013.07.037. View

12.

Birudaraj R, Berner B, Shen S, Li X . Buccal permeation of buspirone: mechanistic studies on transport pathways. J Pharm Sci. 2005; 94(1):70-8. DOI: 10.1002/jps.20208. View

13.

Maurya A, Murthy S . Pretreatment with skin permeability enhancers: importance of duration and composition on the delivery of diclofenac sodium. J Pharm Sci. 2014; 103(5):1497-503. DOI: 10.1002/jps.23938. View

14.

Ju R, Nixon P, Patel M, Tong D . Drug release from hydrophilic matrices. 2. A mathematical model based on the polymer disentanglement concentration and the diffusion layer. J Pharm Sci. 1995; 84(12):1464-77. DOI: 10.1002/jps.2600841214. View

15.

Karavas E, Georgarakis E, Bikiaris D . Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur J Pharm Biopharm. 2006; 64(1):115-26. DOI: 10.1016/j.ejpb.2005.12.013. View

16.

Morishita M, Barichello J, Takayama K, Chiba Y, Tokiwa S, Nagai T . Pluronic F-127 gels incorporating highly purified unsaturated fatty acids for buccal delivery of insulin. Int J Pharm. 2001; 212(2):289-93. DOI: 10.1016/s0378-5173(00)00615-3. View

17.

Boelsma E, Tanojo H, Bodde H, Ponec M . Assessment of the potential irritancy of oleic acid on human skin: Evaluation in vitro and in vivo. Toxicol In Vitro. 2010; 10(6):729-42. DOI: 10.1016/s0887-2333(96)00053-7. View

18.

Patil H, Tiwari R, Upadhye S, Vladyka R, Repka M . Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process. Int J Pharm. 2015; 496(1):33-41. DOI: 10.1016/j.ijpharm.2015.04.009. View

19.

Crowley M, Zhang F, Repka M, Thumma S, Upadhye S, Battu S . Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm. 2007; 33(9):909-26. DOI: 10.1080/03639040701498759. View

20.

Hu F, Jiang S, Du Y, Yuan H, Ye Y, Zeng S . Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces. 2005; 45(3-4):167-73. DOI: 10.1016/j.colsurfb.2005.08.005. View